Tag:
INT-777
Latest Headlines
Latest Headlines
Intercept Pharma hauls in $25M Series B
Intercept Pharmaceuticals' majority shareholder, the Italian biotech Genextra, is pumping a $25 million Series B into its coffers. "This financing is recognition of the success we have had advancing
